Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide for Refractory Cancer Pain
NCT00684242Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- May 2008
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in cancer pain, sponsored by University of Texas MD Anderson Cancer Center. Started May 2008; status: terminated.
02
Drugs
lenalidomide
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT00684242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00684242.